|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (2011)) |
| Is prodrug? | Yes |
| Active form | gabapentin |
IUPAC Name ![]() |
| 2-[1-[[1-(2-methylpropanoyloxy)ethoxycarbonylamino]methyl]cyclohexyl]acetic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8611 | gabapentin enacarbil |
Synonyms ![]() |
| Horizant® |
| Regnite® |
| XP-13512 |
Database Links ![]() |
|
| CAS Registry No. | 478296-72-9 |
| ChEBI | CHEBI:68840 |
| ChEMBL Ligand | CHEMBL1628502 |
| PubChem CID | 9883933 |
| Search Google for chemical match using the InChIKey | TZDUHAJSIBHXDL-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | TZDUHAJSIBHXDL |
| Search PubMed clinical trials | gabapentin enacarbil |
| Search PubMed titles | gabapentin enacarbil |
| Search PubMed titles/abstracts | gabapentin enacarbil |
| Wikipedia | Gabapentin enacarbil |
| Comments |
| Gabapentin enacarbil is a prodrug of gabapentin. It exhibits increased bioavailability compared to gabapentin. |